SL
Siren LLC Portfolio holdings
AUM
$1.93B
This Quarter Return
+22.44%
1 Year Return
+118.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$2B
AUM Growth
–
Cap. Flow
+$2B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
41.3%
Holding
110
New
109
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Kymera Therapeutics
KYMR
|
$141M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$126M |
| 3 |
Scholar Rock
SRRK
|
$90.2M |
| 4 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$78.3M |
| 5 |
argenx
ARGX
|
$77.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 93.6% |
| 2 | Technology | 2.88% |
| 3 | Communication Services | 1.83% |
| 4 | Consumer Discretionary | 0.77% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
51
Rapport Therapeutics
RAPP
$549M
| $7.87M | 0.39% |
+384,197
| New | +$7.87M |
|
52
Neurogene
NGNE
$284M
| $7.38M | 0.37% |
+175,898
| New | +$7.38M |
|
53
Generation Bio
GBIO
$40.3M
| $7.37M | 0.37% |
+298,273
| New | +$7.37M |
|
54
IHS Holding
IHS
$2.43B
| $7.05M | 0.35% |
+2,357,520
| New | +$7.05M |
|
55
CrowdStrike
CRWD
$104B
| $7.01M | 0.35% |
+25,000
| New | +$7.01M |
|
|
VIGL
56
DELISTED
Vigil Neuroscience
VIGL
| $6.77M | 0.34% |
+1,991,038
| New | +$6.77M |
|
57
Foghorn Therapeutics
FHTX
$298M
| $6.71M | 0.34% |
+720,720
| New | +$6.71M |
|
58
ServiceNow
NOW
$191B
| $6.71M | 0.34% |
+7,500
| New | +$6.71M |
|
59
Amazon
AMZN
$2.41T
| $6.47M | 0.32% |
+34,750
| New | +$6.47M |
|
|
BIOA
60
BioAge Labs, Inc. Common Stock
BIOA
$170M
| $6.24M | 0.31% |
+300,000
| New | +$6.24M |
|
61
NVIDIA
NVDA
$4.15T
| $5.94M | 0.3% |
+48,932
| New | +$5.94M |
|
|
SYRS
62
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.56M | 0.28% |
+2,587,372
| New | +$5.56M |
|
63
NovoCure
NVCR
$1.35B
| $5.48M | 0.27% |
+350,884
| New | +$5.48M |
|
64
Lexeo Therapeutics
LXEO
$266M
| $5.46M | 0.27% |
+603,435
| New | +$5.46M |
|
65
Pinduoduo
PDD
$177B
| $5.45M | 0.27% |
+40,401
| New | +$5.45M |
|
|
KLRS
66
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $5.33M | 0.27% |
+286,833
| New | +$5.33M |
|
67
Black Diamond Therapeutics
BDTX
$164M
| $4.55M | 0.23% |
+1,046,517
| New | +$4.55M |
|
68
Alto Neuroscience
ANRO
$97.7M
| $4.48M | 0.22% |
+391,406
| New | +$4.48M |
|
69
Dynatrace
DT
$15.1B
| $4.42M | 0.22% |
+82,729
| New | +$4.42M |
|
70
IonQ
IONQ
$12.2B
| $4.37M | 0.22% |
+500,000
| New | +$4.37M |
|
71
TSMC
TSM
$1.2T
| $4.34M | 0.22% |
+25,000
| New | +$4.34M |
|
|
AGEN
72
Agenus
AGEN
$136M
| $4.25M | 0.21% |
+775,000
| New | +$4.25M |
|
73
Datadog
DDOG
$46.2B
| $3.79M | 0.19% |
+32,925
| New | +$3.79M |
|
74
ADC Therapeutics
ADCT
$370M
| $3.66M | 0.18% |
+1,163,461
| New | +$3.66M |
|
75
Sea Limited
SE
$107B
| $3.54M | 0.18% |
+37,500
| New | +$3.54M |
|